McKesson, CD&R to Buy Option Care for $5.8B
McKesson Corp. and private equity firm Clayton, Dubilier & Rice will acquire Option Care Health Inc. for $5.8 billion, or $32.05 per share, a 37% premium. McKesson will own 49%, with CD&R as the controlling shareholder. Option Care, a major provider of home and outpatient infusion care, will retain its management team. The deal aligns with McKesson's strategy to expand specialty care services, potentially increasing its ownership over time.
How this was made
The 30-second read
Why it matters
The transaction expands McKesson's service footprint while providing Option Care shareholders a premium exit, likely reshaping competitive dynamics in home and outpatient infusion markets.
Market read
A $5.8B M&A deal that could drive short‑term price moves in both stocks and signal broader industry consolidation.
What to watch
Regulatory approval risk and integration challenges could delay expected synergies.
Background
The deal combines a major drug distributor with the largest standalone infusion care provider, aiming to create a vertically integrated specialty care platform.
Ticker impact
McKesson announced a $5.8B acquisition of Option Care, committing $1.4B for a 49% stake.
potential modest downside as investors price in the cash outlay and integration risk
Large M&A transaction with significant cash commitment; market typically reacts cautiously to acquisition spend.
Option Care Health stock jumped 33% after the acquisition announcement at $32.05 per share, a 37% premium.
upward pressure as the premium is priced in and the stock trades at a discount to the offer
The announced premium and immediate price surge indicate strong buying interest; the deal is now certain.
Market effects
Accelerates consolidation in specialty infusion services, pressuring peers and distributors.
U.S. healthcare services sector may see increased M&A activity.
Highlights trend of drug distributors moving into service models worldwide.
Counterpoint
McKesson's cash outlay could strain balance sheet and dilute earnings, suggesting a short‑term pullback.
Key entities
- CompanyMcKesson Corp.
U.S. drug distributor expanding into specialty care services.
- CompanyOption Care Health Inc.
Largest standalone provider of home and outpatient infusion care.
- Private EquityClayton, Dubilier & Rice
Co‑acquirer and controlling shareholder of Option Care.
